SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MARCHETTI ROGER

(Last) (First) (Middle)
C/O CAREFUSION CORPORATION
3750 TORREY VIEW COURT

(Street)
SAN DIEGO CA 92064

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CAREFUSION Corp [ CFN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Human Resources
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2012 M 8,688 A $0 8,688 D
Common Stock 08/15/2012 F(1) 3,188 D $26.69 5,500 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(2) 08/15/2012 M 8,688 (3) (3) Common Stock 8,688 (4) 17,378 D
Restricted Stock Units $0(2) 08/15/2012 A 7,305 (5) (5) Common Stock 7,305 (4) 7,305 D
Options (right to buy) $26.79 08/15/2012 A 49,931 (5) 08/15/2019 Common Stock 49,931 (4) 49,931 D
Explanation of Responses:
1. Withheld to statisfy tax withholding.
2. Each restricted stock unit represents a contingent right to receive one share of CareFusion common stock upon vesting.
3. On 8/15/2012, these restricted stock units vested as to 8,688 shares of common stock. The balance of these restricted stock units will vest as to 8,689 shares on 8/15/2013 and 8,689 shares on 8/15/2014.
4. Granted without payment by grantee.
5. This award was granted pursuant to the CareFusion Corporation 2009 Long-Term Incentive Plan and vests as to one-third of the underlying shares on 8/15/2013, 8/15/2014 and 8/15/2015.
Remarks:
Nathaniel Sisitsky, Attorney-in-Fact 08/16/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.